Johnson & Johnson

JNJNYSEUSD
230.23 USD
0.72 (0.31%)🟢PRE MARKET (AS OF 06:29 AM EDT)
🟢Market: OPEN
Open?$230.11
High?$230.80
Low?$229.85
Prev. Close?$230.65
Volume?3.5K
Avg. Volume?7.8M
VWAP?$230.25
Rel. Volume?0.00x
Bid / Ask
Bid?$229.09 × 100
Ask?$230.23 × 100
Spread?$1.14
Midpoint?$229.66
Valuation & Ratios
Market Cap?555.2B
Shares Out?2.4B
Float?2.4B
Float %?99.9%
P/E Ratio?20.71
P/B Ratio?6.81
EPS?$11.13
Dividend?2.23%
Ex-Dividend?2026-05-26
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.03Adequate
Quick Ratio?0.77Weak
Cash Ratio?0.36Low
Debt/Equity?0.59Moderate
ValuationFAIRLY VALUED
Score
61/100
P/E?
20.7FAIR
P/B?
6.81FAIR
P/S?
5.89FAIR
P/FCF?
28.8FAIR
EV/EBITDA?
17.7FAIR
EV/Sales?
6.19HIGH
Returns & Efficiency
ROE?
32.9%STRONG
ROA?
13.5%STRONG
Cash Flow & Enterprise
FCF?$19.3B
Enterprise Value?$583.4B
News
Profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Employees
140.8K
Market Cap
555.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1944-09-25
Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455